FDA approves AstraZeneca’s Imfinzi plus EV for bladder cancer
AstraZeneca said its Imfinzi plus EV regimen has been approved in the US for bladder cancer.
Story updates
07:12:30 AM UTC
SquawkNews
... AstraZeneca Based on VOLGA Phase III trial data which showed a 49% reduction in risk of recurren